Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine neuroprotection in elective cardiac or abdominal surgery
2013-000823-15Phase 4Completed
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Nov 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of dexmedetomidine in postoperative delirium (POD) and post-operative cognitive decline (POCD) (2 arms), sponsored by Charité – Universitätsmedizin Berlin. Primary endpoint: Incidence of postoperative delirium. Started Nov 2013; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postoperative delirium (POD)post-operative cognitive decline (POCD)
Beyond the preview
Go deeper on 2013-000823-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-000823-15.